Results 31 to 40 of about 299,239 (347)
Drug eruption: A mimicker of Coronavirus disease-2019 rash
Turkderm Turkish Archives of Dermatology and Venereology, 2022 Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infections can be associated with several cutaneous lesions, among which maculopapular rash is the most common.
Tülin Ergun +6 more
doaj +1 more source
Drug interactions in COVID-19 treatment. Systematic review [PDF]
Farmacja Polska, 2022 The COVID-19 pandemic has driven the experimental, off-label treatments with co-administration of supportive therapies for many patients with severe infections and coexisting chronic conditions. This situation has inevitably led to polypharmacy, which is
Arkadiusz Adamiszak +4 more
doaj +1 more source
Impact of montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19): protocol for an investigator-initiated open labeled randomized controlled pragmatic trial [PDF]
, 2021 Background: Montelukast, a safe drug widely use in asthmatic patients, may be an adjuvant in the treatment of Covid-19, either by improving lung injury and inflammation, or by acting as an anti-viral drug.
Almeida, J +13 more
core +1 more source
A review of potential pharmacological treatments of COVID-19: an evidence-based perspective [PDF]
, 2020 Coronaviruses (CoVs) typically manifest as mild to severe respiratory tract infections. No drug is approved by US food and drug administration (FDA) for the treatment of patients with coronaviruses infection. With growing COVID-19 pandemic globally, need
Dhamija, Puneet +3 more
core +2 more sources
The effectiveness of dexamethasone as a combination therapy for COVID-19 [PDF]
, 2022 Coronavirus disease 2019 (COVID-19) was reported as a global pandemic in March 2020 after invading many countries and leaving behind tens of thousands of infected patients in a brief time span.
NAMAZI, NADER
core +2 more sources
Future Internet, 2021 The current global crisis caused by COVID-19 almost halted normal life in most parts of the world. Due to the long development cycle for new drugs, drug repositioning becomes an effective method of screening drugs for COVID-19. To find suitable drugs for
Mingxuan Che +4 more
doaj +1 more source
A Data Driven Approach to Profile Potential SARS-CoV-2 Drug Interactions Using TylerADE [PDF]
, 2021 We use a data driven approach on a cleaned adverse drug reaction database to determine the reaction severity of several covid-19 drug combinations currently under investigation.
Boyett, Matthew +4 more
core +2 more sources
Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment [PDF]
Frontiers in Immunology, 2021 The magnitude of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has prompted the repurposing of several drugs to quickly stop the morbidity, mortality, and spread of this new disease.
openaire +4 more sources
Drugs for COVID-19 Treatment: A New Challenge
Applied Biochemistry and Biotechnology, 2023 COVID-19 infection is a new disease and our knowledge is limited; day in and day out more and more interesting yet diverse observations are reported by the different research groups from different corners of the world. So, there is an urgent requirement of the invention of some effective and efficient drugs that can carry out the end of the deadly ...
Pratik Talukder +5 more
openaire +2 more sources
Different COVID-19 treatments’ impact on hospital length of stay
European Journal of Medical Research, 2023 Importance COVID-19 has adversely affected global healthcare infrastructure since 2019. Currently, there are no large-scale published reports on the efficacy of combination therapy of dexamethasone, remdesivir, and tocilizumab on COVID-19 patients ...
Satori Iwamoto +8 more
doaj +1 more source